Medicine and Dentistry
Hepatocellular Carcinoma
100%
Sarcomatoid
100%
Immunotherapy
100%
Neoplasm
57%
Lenvatinib
42%
Radiofrequency Ablation
28%
Arterial Embolization
28%
Drug Therapy
14%
Atezolizumab
14%
Bevacizumab
14%
Minoxidil
14%
Hypoxia
14%
Ablation Therapy
14%
Interventional Therapy
14%
Keyphrases
Combination Immunotherapy
100%
Sarcomatoid Hepatocellular Carcinoma
100%
Lenvatinib
42%
Radiofrequency Ablation
28%
Transcatheter Arterial Embolization
28%
Tumor
14%
Older Men
14%
Fever
14%
Poor Prognosis
14%
Pharmacological Treatment
14%
Attenuation
14%
Epithelial-mesenchymal Transition
14%
Atezolizumab Plus Bevacizumab
14%
Hypoxia
14%
Tumor Regrowth
14%
Physical Status
14%
Tumor Control
14%
Tumor Shrinkage
14%
Interventional Therapy
14%
Ablation Therapy
14%
Arterial Enhancement
14%
Rare Phenotype
14%
Hepatocellular Carcinoma Rupture
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Immunotherapy
100%
Neoplasm
57%
Lenvatinib
42%
Atezolizumab
14%
Bevacizumab
14%
Minoxidil
14%
Hypoxia
14%